2685 studies found for:    "Hepatitis A"
Show Display Options
Rank Status Study
21 Active, not recruiting The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines
Condition: Hepatitis A
Interventions: Biological: Attenuated HAV Vaccine, H2 Strain;   Biological: Attenuated HAV Vaccine, L-A-1 Strain;   Biological: Inactivated HAV Vaccine, Lu8 Strain;   Biological: Inactivated HAV Vaccine, TZ84 Strain
22 Completed Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian Children
Conditions: Acute Hepatitis A;   Hepatitis
Intervention: Procedure: Serum sample
23 Completed Hepatitis A Vaccine in Patients With Immunomodulating Drugs
Condition: Response to Hepatitis A Vaccine
Intervention: Biological: hepatitis A vaccine ( HAVRIX or EPAXAL)
24 Completed Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine
Conditions: Measles;   Mumps;   Rubella;   Hepatitis A
Interventions: Biological: Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella;   Biological: Attenuated Measles Mumps Rubella; Inactivated Hep A vaccine
25 Completed
Has Results
Lamivudine and Adefovir to Treat Chronic Hepatitis B
Conditions: HBV (Hepatitis B Virus);   Hepatitis B;   Hepatitis
Interventions: Drug: Lamivudine and adefovir;   Drug: Adefovir alone
26 Completed
Has Results
A Study to Evaluate the Safety and Immunogenicity of the Hepatitis A Virus Vaccine HAVpur in Healthy Young Children
Condition: Hepatitis A
Interventions: Biological: HAVpur Junior;   Biological: Havrix 720 Junior
27 Not yet recruiting Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®
Condition: Hepatitis A
Intervention: Procedure: Blood sampling
28 Completed
Has Results
Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule
Condition: Hepatitis A
Intervention: Biological: Havrix™
29 Completed
Has Results
Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule
Condition: Hepatitis A
Intervention: Biological: Havrix™
30 Completed Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines
Condition: Hepatitis A
Interventions: Biological: Epaxal;   Biological: Havrix 720
31 Recruiting Non-invasive Biomarkers of Fibrosis in Pediatric Viral Hepatitis
Conditions: Viral Hepatitis;   Liver Fibrosis;   Liver Disease;   Hepatitis B;   Hepatitis C
Intervention:
32 Not yet recruiting Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico
Condition: Hepatitis A
Intervention: Other: Data collection
33 Completed
Has Results
Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years
Conditions: Hepatitis B;   Hepatitis A
Interventions: Biological: Twinrix™ Adult;   Biological: Twinrix™ Junior
34 Completed
Has Results
ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients
Conditions: Chronic Hepatitis C;   Hepatitis C (HCV);   Hepatitis C Genotype 1
Interventions: Drug: ABT-450;   Drug: ABT-333;   Drug: ABT-267;   Drug: Ribavirin;   Drug: Ritonavir
35 Unknown  Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
Conditions: Hepatitis C;   Hepatitis B;   Autoimmune Hepatitis;   Liver Cirrhosis, Biliary;   Cholangitis, Sclerosing
Intervention:
36 Recruiting Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults
Conditions: Chronic Hepatitis C;   Hepatitis C (HCV);   Hepatitis C Genotype 1a
Interventions: Drug: ombitasvir/ABT-450/ritonavir;   Drug: dasabuvir;   Drug: ribavirin
37 Recruiting Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults
Conditions: Chronic Hepatitis C;   Hepatitis C (HCV);   Hepatitis C Genotype 1a
Interventions: Drug: ombitasvir/ABT-450/ritonavir;   Drug: dasabuvir;   Drug: ribavirin
38 Not yet recruiting PCV13 + Hepatitis A Vaccine for Adults
Conditions: Measurement of Immune Response to Prevenar13;   Measurement of Immune Response to Hepatitis A
Interventions: Biological: Prevenar13;   Biological: Hepatitis A vaccine
39 Active, not recruiting A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study
Conditions: Chronic Hepatitis C;   Hepatitis C (HCV);   Hepatitis C Genotype 1
Interventions: Drug: ABT-450/r;   Drug: ABT-267;   Drug: pegylated interferon alpha-2a (pegIFN);   Drug: Ribavirin (RBV)
40 Completed
Has Results
Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months
Conditions: Hepatitis A Vaccine;   Hepatitis A
Interventions: Biological: Havrix™;   Biological: Infanrix™;   Biological: ActHIB™

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years